Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Agenus Inc (NQ: AGEN )

3.160 USD -0.235 (-6.92%)
Official Closing Price Updated: 7:50 PM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Agenus Inc

< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Agenus to Host Annual Meeting of Stockholders
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies1, invites investors and the general public... 
From PR Newswire
MiMedx Announces Comprehensive Board Refreshment Plan in Cooperation with Prescience Point
Six New Directors to Join the Board 
From PR Newswire
Biotechs That Successfully Combat Cancer Could See Blockbuster Returns
NetworkNewsWire Editorial Coverage 
From PR Newswire
Agenus Inc (AGEN) Q1 2019 Earnings Call Transcript
AGEN earnings call for the period ending March 31, 2019. 
Tags AGEN Market News
From Motley Fool
The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stock To Debut
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags SELB RETA CDMO
From Benzinga
Agenus Reports First Quarter 2019 Financial Results and Provides Corporate Update
- Gilead partnership yields $150M & first milestone of $7.5M 
From PR Newswire
Agenus to Report First Quarter 2019 Financial Results on May 9, 2019 and Host Conference Call and Webcast
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies1, will release its first quarter 2019... 
From PR Newswire
Benzinga's Top Upgrades, Downgrades For April 22, 2019
Top Upgrades Analysts at Raymond James upgraded Rent-A-Center Inc (NASDAQ: RCII) from Outperform to Strong Buy. Rent-A-Center ... 
Tags AGEN Analyst Ratings OKE
From Benzinga
Analysts See 21% Gains Ahead For PXSG
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Biotechs Strive to Provide Patients With More Affordable Treatment Options
FinancialBuzz.com News Commentary 
From PR Newswire
Detailed Research: Economic Perspectives on Agenus, Warrior Met Coal, Cubic, Nielsen Holdings Plc, Leidos, and Limoneira — What Drives Growth in Today's Competitive Landscape
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Agenus Inc. (NASDAQ:AGEN),... 
From GlobeNewswire News Releases
Agenus Begins Dosing with Next-Gen Anti-CTLA-4 Antibody
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune-modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies1, today announced that the first patient... 
From PR Newswire
Short Interest Makes 12.2% Move For AGEN
The most recent short interest data has been released for the 03/15/2019 settlement date, which shows a 1,080,838 share increase in total short interest for Agenus Inc (AGEN), to 9,973,177, an increase... 
Tags Stocks
From Market News Video
IAVI Announces First-in-Human Clinical Trial of Native-like HIV Envelope Vaccine Candidate
IAVI announces Phase I trial to evaluate safety and immunogenicity of engineered envelope protein HIV vaccine candidate 
From Business Wire News Releases
Therapies Trying to Fight Against Cancer
FinancialBuzz.com News Commentary 
From PR Newswire
Agenus Announces Clinical Appointments
- Dr. Manuel Hidalgo, MD, PhD as Strategic Advisor 
From PR Newswire
3 Top Growth Stocks to Buy Right Now
Surprise! This retailer and lesser-known biotechnology company could be potential multibaggers. 
Tags FIVE Market News AGEN
From Motley Fool
Agenus Inc (AGEN) Q4 2018 Earnings Conference Call Transcript
AGEN earnings call for the period ending December 31, 2018. 
Tags AGEN Market News
From Motley Fool
Agenus Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
- Gilead collaboration results in cash infusion of $150M; first milestone payment of $7.5M triggered 
From PR Newswire
Agenus Milestone Triggers $7.5M Payment from Gilead
- FDA has accepted IND filing for AGEN1423 
From PR Newswire
Analysts Predict 18% Gains Ahead For IEIH
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Agenus to Report Fourth Quarter and Full Year 2018 Financial Results on March 14, 2019 and Host Conference Call and Webcast
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies1, will release its fourth quarter and full... 
From PR Newswire
The 3 Oldest Members of Biotech's Billion-Burned Club
These biopharmaceutical startups have been losing their investors' money for decades. 
Tags GILD NVAX Market News
From Motley Fool
Analysis: Positioning to Benefit within Micron Technology, Caterpillar, Agenus, Fossil Group, Marathon Petroleum, and Geo Group — Research Highlights Growth, Revenue, and Consolidated Results
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Micron Technology, Inc.... 
From GlobeNewswire News Releases
71 Biggest Movers From Yesterday
Gainers Riot Blockchain, Inc. (NASDAQ: RIOT) shares gained 34.82 percent to close at $3.33 on Tuesday amid strength in the ... 
Tags PCG EVH FFHL
From Benzinga
Agenus Launches First Asset-Backed Digital-Security Offering in Healthcare
-- Agenus Conference Call and Live Webcast Scheduled for 11:00a.m. ET today -- 
From PR Newswire
Agenus to Host Call to Launch First Asset-Backed Digital-Security Offering in Healthcare on February 19, 2019
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies1, announced today that its Biotech... 
From PR Newswire
Why Agenus Inc. Stock Took Flight in January
Agenus' stock crushed it last month. Here's why. 
Tags Market News AGEN GILD
From Motley Fool
IEIH's Holdings Could Mean 20% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Investor Movement Index January Summary
Monthly Summary The IMX decreased for the fourth month in a row in January, moving down 2.95 percent to 4.28 from a previous score of ... 
Tags GE AGEN T
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.